Skip to main content
. 2024 Feb 19;16(2):e54443. doi: 10.7759/cureus.54443

Table 4. Antimicrobial resistance pattern.

S: susceptibility, I: intermediate, R: resistant, HAP: hospital-acquired pneumonia, VAP: ventilator-associated pneumonia

Parameters Day 0 of VAP/HAP diagnosis
Antibiotics Total S I R
Piperacillin-tazobactam 85 12 (14.12%) 0 (0%) 73 (85.88%)
Meropenem 62 11 (17.74%) 1 (1.61%) 50 (80.65%)
Imipenem 89 12 (13.48%) 9 (10.11%) 68 (76.4%)
Amikacin 97 22 (22.68%) 8 (8.25%) 67 (69.07%)
Gentamicin 84 18 (21.43%) 2 (2.38%) 64 (76.19%)
Ceftazidime-avibactam 50 28 (56%) 0 (0%) 22 (44%)
Colistimethate sodium 102 - 99 (97.06%) 3 (2.94%)